Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Adicionar filtros








Intervalo de ano
1.
Acta Pharmaceutica Sinica ; (12): 604-608, 2012.
Artigo em Chinês | WPRIM | ID: wpr-276273

RESUMO

Effects of the effective components group of Xiaoshuantongluo formula (XECG) on rat acute blood stasis model were studied under the guidance of the concept of effective components group. Rat acute blood stasis model was induced by subcutaneous injection of epinephrine combined with ice water bath. Hemorheology indices such as whole blood viscosity, plasma viscosity, erythrocyte aggregation index and platelet aggregation rate; coagulation parameters including PT, APTT, TT and FIB; 6-keto-PGF1alpha, TXB2 and D-dimer levels were determined to evaluate the effects of XECG. The results showed that XECG significantly reduced ADP-induced platelet aggregation, but showed little influence on the whole blood viscosity, plasma viscosity and erythrocyte aggregation rate. XECG extended PT and TT slightly, but had no effects on APTT and FIB content. D-dimer levels significantly decreased after administration of XECG with a little decrease of TXB2, but the content of 6-keto-PGF1alpha did not change significantly. The results suggest that the role of XECG of anti-aggregation is more prominent.


Assuntos
Animais , Masculino , Ratos , 6-Cetoprostaglandina F1 alfa , Sangue , Coagulação Sanguínea , Transtornos da Coagulação Sanguínea , Sangue , Viscosidade Sanguínea , Combinação de Medicamentos , Medicamentos de Ervas Chinesas , Farmacologia , Agregação Eritrocítica , Produtos de Degradação da Fibrina e do Fibrinogênio , Metabolismo , Hemorreologia , Tempo de Tromboplastina Parcial , Plantas Medicinais , Química , Agregação Plaquetária , Tempo de Protrombina , Distribuição Aleatória , Ratos Sprague-Dawley , Tempo de Trombina , Tromboxano B2 , Sangue
2.
Acta Pharmaceutica Sinica ; (12): 642-649, 2011.
Artigo em Chinês | WPRIM | ID: wpr-348906

RESUMO

There are growing evidences that pinocembrin has better neuroprotective effect. In the present study, the effect of pinocembrin on mitochondrial respiratory function was evaluated in global brain ischemia/ reperfusion (4-vessel occlusion, 4-VO) rats. The results showed that pinocembrin improved the respiratory activity of 4-VO brain mitochondria, through increasing ADP/O, state 3 respiration state (V3), respiration control rate index (RCI) and oxidative phosphorylation rate (OPR). And then, the effect of pinocembrin on brain mitochondria was verified in vitro. The results showed that pinocembrin increased ADP/O, state 3 respiration state, respiration control rate index, oxidative phosphorylation rate in NADH/FADH2 dependent respiratory chain and decreased state 4 respiration state (V4) in NADH dependent respiratory chain. Pinocembrin improved ATP content in brain mitochondria in vitro and in SH-SY5Y cells.


Assuntos
Animais , Masculino , Ratos , Difosfato de Adenosina , Metabolismo , Trifosfato de Adenosina , Isquemia Encefálica , Patologia , Linhagem Celular Tumoral , Respiração Celular , Flavanonas , Farmacologia , Hipocampo , Patologia , Mitocôndrias , Fisiologia , Neuroblastoma , Metabolismo , Patologia , Neurônios , Fármacos Neuroprotetores , Farmacologia , Oxigênio , Metabolismo , Ratos Sprague-Dawley
3.
Acta Pharmaceutica Sinica ; (12): 801-806, 2010.
Artigo em Chinês | WPRIM | ID: wpr-354529

RESUMO

The aim of this study is to investigate the effects of the metformin on the formation of hepatic fibrosis in type 2 diabetic rats and discuss its mechanism of liver-protecting activity. After SD rats were fed with high-fat and high-sucrose diet for four weeks, low-dose streptozotocin (STZ) was injected intraperitoneally to make the animal mode of type 2 diabetes. Then, all diabetic rats was fed with the high-fat diet and metformin (ig, 100 mg x kg(-1)) was given orally to metformin group for four months. After the last administration, fasting blood glucose was determined. The livers were removed to calculate the hepatic coefficient and to make HE and Picro acid-Sirius red staining, immunohistochemistry (alpha-SMA and TGFbeta1) and TUNEL staining in order to evaluate the effect of metformin on the hepatic fibrosis. The animal model of type 2 diabetes with hepatic fibrosis was successfully made. Metformin can significantly alleviate the lesions of hepatic steatosis and fibrosis, markedly reduce the expressions of alpha-SMA and TGFbeta1 in liver tissue of type 2 diabetic rats. However, TUNEL staining result suggested that metformin could not reduce apoptosis of hepatocytes. The results suggest that metformin can inhibit the formation of hepatic fibrosis in type 2 diabetes.


Assuntos
Animais , Feminino , Masculino , Ratos , Actinas , Metabolismo , Apoptose , Glicemia , Metabolismo , Peso Corporal , Diabetes Mellitus Experimental , Tratamento Farmacológico , Metabolismo , Patologia , Diabetes Mellitus Tipo 2 , Tratamento Farmacológico , Metabolismo , Patologia , Dieta Hiperlipídica , Hepatócitos , Patologia , Hipoglicemiantes , Farmacologia , Usos Terapêuticos , Fígado , Metabolismo , Patologia , Cirrose Hepática Experimental , Tratamento Farmacológico , Metabolismo , Patologia , Metformina , Farmacologia , Usos Terapêuticos , Distribuição Aleatória , Ratos Sprague-Dawley , Estreptozocina , Fator de Crescimento Transformador beta1 , Metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA